Welcome
Support Centre
12 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes


International Standard Randomised Controlled Trial Number Register
Showing records: 301 to 350 of 617
SEARCH FOR RESULTS ORDER DIRECTION MAX RESULTS
RESULT PAGE
|< < 3 4 5 6 7 8 9 10 11 > >|
301 An evaluation of potential therapies to inhibit cerebral emboli in dementia
ISRCTN: ISRCTN43384456
Sponsor: University Hospital of South Manchester (UK)
Date assigned: 06 July 2007
302 A randomised, double-blind, placebo-controlled study of Glypromate® in patients undergoing cardiopulmonary bypass surgery: Studying Neurons Using Glypromate® - second study
ISRCTN: ISRCTN47685900
Sponsor: Neuren Pharmaceuticals Limited (New Zealand)
Date assigned: 05 July 2007
303 Telephone-based behaviour-therapeutic intervention to reduce family caregiver burden in chronic stroke (Telefongestützte verhaltenstherapeutische Intervention zur entlastung Pflegender angehöriger von Schlaganfall-betroffenen)
ISRCTN: ISRCTN86289718
Sponsor: Robert Bosch Hospital (Robert-Bosch-Krankenhaus) (Germany)
Date assigned: 22 June 2007
304 Resistance Exercise in Already-active Diabetic Individuals (READI)
ISRCTN: ISRCTN59775422
Sponsor: Ottawa Hospital Research Institute (OHRI) (Canada) - formerly Ottawa Health Research Institute
Date assigned: 22 June 2007
305 Discovery of novel biomarkers in peripheral arterial disease / metabolic syndrome
ISRCTN: ISRCTN46806801
Sponsor: University of Dundee (UK)
Date assigned: 19 June 2007
306 INtramyocardial application of STEM cells in combination with transmyocardial laser revascularisation in coronary artery bypass graft patients
ISRCTN: ISRCTN49998633
Sponsor: Heinrich-Heine-University (Germany)
Date assigned: 15 June 2007
307 INcidence of VENous Thromboembolism after acute stroke in China
ISRCTN: ISRCTN34425939
Sponsor: Beijing Tiantan Hospital (China)
Date assigned: 06 June 2007
308 The TASCFORCE Project: Tayside Screening For risk of Cardiac Events and the effect of statin on risk reduction
ISRCTN: ISRCTN38976321
Sponsor: University of Dundee (UK)
Date assigned: 05 June 2007
309 BENznidazole Evaluation For Interrupting Trypanosomiasis pilot trial
ISRCTN: ISRCTN13967269
Sponsor: Hamilton Health Science Corporation (HHSC) (Canada)
Date assigned: 01 June 2007
310 Transfusion Alternatives Pre-operatively in Sickle cell disease
ISRCTN: ISRCTN00862331
Sponsor: NHS Blood and Transplant (NHSBT) (UK)
Date assigned: 30 May 2007
311 Cervical Artery Dissection In Stroke Study
ISRCTN: ISRCTN44555237
Sponsor: St George's University of London (UK)
Date assigned: 18 May 2007
312 Community Cardiovascular Health Awareness Program
ISRCTN: ISRCTN50550004
Sponsor: McMaster University (Canada)
Date assigned: 09 May 2007
313 Does vitamin D improve markers of vascular health in stroke patients?
ISRCTN: ISRCTN28737567
Sponsor: University of Dundee (UK)
Date assigned: 01 May 2007
314 Training Caregivers after Stroke (TRACS)
ISRCTN: ISRCTN49208824
Sponsor: University of Leeds (UK)
Date assigned: 30 April 2007
315 STroke inpatient secOndary Prevention: current status and continuous care improvement
ISRCTN: ISRCTN17207064
Sponsor: Beijing Tiantan Hospital (China)
Date assigned: 26 April 2007
316 Coenzyme Q10 as adjunctive treatment of chronic heart failure: a randomised, double-blind, multicentre trial with focus on SYMptoms, BIOmarker status (Brain-Natriuretic Peptide [BNP]), and long-term outcome (hospitalisations/mortality)
ISRCTN: ISRCTN94506234
Sponsor: Pharma Nord ApS (Denmark)
Date assigned: 23 April 2007
317 A double-blind, placebo controlled study to assess the safety and preliminary efficacy of PSD506 in treatment-naïve or previously treated (washed out) patients with symptoms of overactive bladder
ISRCTN: ISRCTN97355181
Sponsor: Plethora Solutions Ltd (UK)
Date assigned: 23 April 2007
318 A double-blind, placebo controlled, pilot study to assess the safety and preliminary efficacy of PSD506 in treatment-naïve or previously treated (washed out) patients with benign prostatic obstruction and lower urinary tract symptoms
ISRCTN: ISRCTN71613863
Sponsor: Plethora Solutions Limited (UK)
Date assigned: 20 April 2007
319 An open-label, escalating dose, proof of concept study to determine the effects of single oral doses of PSD506 on unstable urinary bladder contractions induced by volume provocation in subjects with detrusor hyper-reflexia secondary to spinal injuries above T12
ISRCTN: ISRCTN81647490
Sponsor: Plethora Solutions Ltd (UK)
Date assigned: 20 April 2007
320 A phase II, multi-centre, double-blind, placebo-controlled, 2-way cross-over study to evaluate efficacy, plasma concentrations and safety of 0.25 mL of 20 % w/w PSD503 for topical application in female volunteer patients with stress urinary incontinence
ISRCTN: ISRCTN39853232
Sponsor: Plethora Solutions Ltd (UK)
Date assigned: 20 April 2007
321 LIMIT-1: Lowering the Incidence of vascular complications with Metformin in patients with Impaired glucose Tolerance and a recent transient ischaemic attack or minor ischaemic stroke: a phase II randomised, controlled trial
ISRCTN: ISRCTN54960762
Sponsor: Erasmus Medical Centre (The Netherlands)
Date assigned: 11 April 2007
322 Amphetamine for stroke recovery: a clinical and magnetic resonance imaging study
ISRCTN: ISRCTN12247669
Sponsor: Sunnybrook Health Sciences Centre (Canada)
Date assigned: 30 March 2007
323 The pharmacogenetics of aspirin resistance
ISRCTN: ISRCTN71079188
Sponsor: Royal Group of Hospitals Trust (UK)
Date assigned: 14 March 2007
324 PRoximal Embolic Protection in Acute myocardial infarction and Resolution of ST-Elevation-combined embolic protection and thrombectomy during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomised comparison using the PROXIS™ device
ISRCTN: ISRCTN71104460
Sponsor: Academic Medical Centre (AMC) (Netherlands)
Date assigned: 05 March 2007
325 Aspirin and simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes
ISRCTN: ISRCTN48110081
Sponsor: Consortium Mario Negri South (Consorzio Mario Negri Sud) (Italy)
Date assigned: 05 March 2007
326 HPS2-THRIVE: Treatment of High density lipoprotein to Reduce the Incidence of Vascular Events
ISRCTN: ISRCTN29503772
Sponsor: University of Oxford (UK)
Date assigned: 01 March 2007
327 The Efficacy of Self-MONitoring of blood glucose in patients with type two diabetes mellitus
ISRCTN: ISRCTN49814766
Sponsor: University of Ulster (UK)
Date assigned: 26 February 2007
328 Quetiapine augmentation to serotonin reuptake inhibitors for patients with obsessive compulsive disorder: a double-blind, placebo-controlled study
ISRCTN: ISRCTN40781401
Sponsor: University Medical Centre Utrecht (UMCU) (The Netherlands)
Date assigned: 23 February 2007
329 POET: Prevention Of Endometrial Tumours
ISRCTN: ISRCTN22037489
Sponsor: St George's, University of London & Queen Mary and Westfield College, University of London (UK)
Date assigned: 21 February 2007
330 Do positive end-expiratory pressure-induced changes in cardiac output indicate fluid responsiveness in anaesthetised patients?
ISRCTN: ISRCTN07173607
Sponsor: Anaesthesia and Intensive Care Medicine of North Denmark Region (Denmark)
Date assigned: 14 February 2007
331 Autologous bone marrow-derived cells for cardioprotection during heart surgery
ISRCTN: ISRCTN22639386
Sponsor: University Hospitals of Leicester NHS Trust (UK)
Date assigned: 14 February 2007
332 HYbrid-Revascularisation In Senescent Cohorts: a prospective randomised comparative trial between minimally-invasive coronary revascularisation treatment without extra-corporeal circulation (off pump coronary surgery) and combined stent-implantation versus conventionally surgical treatment in cardioplegia with the aid of extra-corporeal circulation
ISRCTN: ISRCTN53284852
Sponsor: Martin Luther-University Halle-Wittenberg (Germany)
Date assigned: 13 February 2007
333 Effectiveness of the use of a “shoulder-joint-functionorthesis“ in shoulder-joint-subluxation after ischaemic brain stroke to avoid post hemiplegics shoulder-hand-syndrome
ISRCTN: ISRCTN61157551
Sponsor: Neurologische Klinik Bad Neustadt GmbH (Germany)
Date assigned: 13 February 2007
334 A randomised controlled trial of median Sternotomy versus anterolateral left Thoracotomy on morbidity and healthcare resource use in patients having off-pump coronary artery bypass surgery
ISRCTN: ISRCTN77366282
Sponsor: United Bristol NHS Healthcare Trust (UK)
Date assigned: 09 February 2007
335 An international, multicentre prospective single arm study to investigate procedural, clinical and angiographic outcomes using the Taxus Liberte stent, with improved side branch access, following the provisional side branch T-stenting approach, in patients with complex lesions
ISRCTN: ISRCTN82823121
Sponsor: New Nantes Private Clinics (Nouvelles Cliniques Nantaises) (France)
Date assigned: 08 February 2007
336 The effects of epidermal growth factor receptor inhibition on pulmonary arterial hypertension associated with systemic sclerosis
ISRCTN: ISRCTN75611179
Sponsor: VU University Medical Centre (The Netherlands)
Date assigned: 01 February 2007
337 Physiological effects of goal directed therapy (incorportating dopexamine infusion) in patients undergoing major surgery
ISRCTN: ISRCTN94850719
Sponsor: Queen Mary's University of London (UK)
Date assigned: 29 January 2007
338 The Greater Green Triangle Diabetes Prevention Project
ISRCTN: ISRCTN38031372
Sponsor: The Australian Government Department of Health and Ageing (Australia)
Date assigned: 22 January 2007
339 A randomised, single-blind, two-limbed, parallel-group study to compare the effectiveness of ‘individualised traditional Korean acupuncture’ with one of ‘standardised acupuncture’ in Korean patients with knee osteoarthritis
ISRCTN: ISRCTN40706107
Sponsor: Korea Institute of Oriental Medicine (South Korea)
Date assigned: 16 January 2007
340 Prevention Of Morbidity In Sickle cell disease pilot phase
ISRCTN: ISRCTN29004071
Sponsor: Institute of Child Health (UK)
Date assigned: 12 January 2007
341 Influence of Dextran-70 on Systemic Inflammatory Response and myocardial ischaemia-reperfusion following cardiac operations
ISRCTN: ISRCTN38289094
Sponsor: European Society of Anesthesiologists (ESA) (Belgium)
Date assigned: 03 January 2007
342 CArdiometabolic Risk reDuctIOn by Rimonabant: the Effectiveness in Daily practice and its USE
ISRCTN: ISRCTN63367873
Sponsor: University Maastricht (UM) (The Netherlands)
Date assigned: 28 December 2006
343 The variations in small vascular function and arterial compliance during the menstrual cycle in young healthy women (De cyclus afhankelijke variatie in de microcirculatie bij jonge gezonde ovulerende vrouwen)
ISRCTN: ISRCTN32882895
Sponsor: VU University Medical Center (The Netherlands)
Date assigned: 28 December 2006
344 Influence of long term administration of fluoxetine on cerebral threshold and muscle activation patterns in chronic stroke
ISRCTN: ISRCTN46063747
Sponsor: Rehabilitation Centre 'The Roessingh' Enschede (The Netherlands)
Date assigned: 28 December 2006
345 REducing Deaths due to OXidative Stress: the REDOXS© Study
ISRCTN: ISRCTN48486094
Sponsor: Queen's University (Canada)
Date assigned: 27 December 2006
346 Does allopurinol/urate lowering by xanthine oxidase inhibition have an impact on arterial stiffness in stroke survivors?
ISRCTN: ISRCTN98638368
Sponsor: University of Dundee (UK)
Date assigned: 13 December 2006
347 Multicentric prospective study for Therapy of Erectile Dysfunction After nerve sparing radical Prostatectomy: sildenafil (50 mg daily dosing) versus intracorporeal injection of alprostadil (2.5 µg - 10 µg 3/week)
ISRCTN: ISRCTN32957197
Sponsor: Johannes Gutenberg Universität Mainz (Germany)
Date assigned: 04 December 2006
348 Imaging the neural correlates of rehabilitation in Wernicke's aphasia
ISRCTN: ISRCTN68939136
Sponsor: Joint UCLH and UCL Biomedical Research Unit (UK)
Date assigned: 04 December 2006
349 A randomised, double-masked phase III study of the efficacy and safety of Avastin® (bevacizumab) intravitreal injections compared to best available therapy in subjects with choroidal neovascularisation secondary to age-related macular degeneration
ISRCTN: ISRCTN83325075
Sponsor: Moorfields Eye Hospital NHS Foundation Trust (UK)
Date assigned: 29 November 2006
350 TiMing of Intervention in patients with Acute Coronary Syndromes
ISRCTN: ISRCTN20993046
Sponsor: Population Health Research Institute (PHRI) (Canada)
Date assigned: 27 November 2006
RESULT PAGE
|< < 3 4 5 6 7 8 9 10 11 > >|
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central